Indefinite Delivery Contract 75N92019D00016

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded an Indefinite Delivery Contract (IDC) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $13.3 million single-award contract supports the Gene Therapy Resource Program (GTRP), which aims to advance translational gene therapy research. Under this IDC, The Trustees of the University of Pennsylvania provides resources and services through three core laboratories: 1) Pharmacology and Toxicology Core Laboratory, 2) Preclinical Vector Core Laboratory, and 3) Clinical Coordinating Center. The contract has a period of performance through June 2025 and does not utilize any set-aside designations. Several task orders have been issued to date, including $213,371 for core administrative tasks, $1.8 million for preclinical vector core laboratory activities, and over $1.4 million for additional preclinical vector core laboratory work. This IDC allows the NHLBI to efficiently procure a range of specialized preclinical research services from The Trustees of the University of Pennsylvania to support its gene therapy research programs and objectives.